RECRUITING

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also seeks to understand the role of personalized peer support in enhancing engagement and outcomes of digital CBT interventions. By leveraging existing infrastructure for delivering virtual peer support interventions, tailored digital CBT programs for individuals with SCD, and partnerships with CBOs, the study aims to provide valuable insights into the feasibility and effectiveness of digital CBT as a pain management strategy for this vulnerable population.

Official Title

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain: Promoting Engagement in Cognitive Behavioral Therapy

Quick Facts

Study Start:2025-03
Study Completion:2028-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06374238

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:16 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Aged 16 to 30 years of age at time of enrollment
  2. 2. Sickle Cell Disease diagnosis of any genotype based on referral or documentation
  3. 3. Reports chronic pain (≥4 days/week for past 3 months or more) OR A) Being prescribed pain medication to be taken (≥4 days/week for past 3 months or more) OR B) Taking pain medication (≥4 days/week for past 3 months or more) OR C) Receiving non-pharmaceutical pain treatment (≥4 days/week for past 3 months or more)
  4. 4. Access to an iOS or Android mobile device with internet access
  1. 1. Unable to speak or read English
  2. 2. Prior hematopoietic stem cell transplant for sickle cell disease

Contacts and Locations

Study Contact

Steffi Siebert
CONTACT
877-649-0176
presencestudy@pitt.edu

Principal Investigator

Charles Jonassaint, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Ana Radovic, MD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Alicia Colvin, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Charles Jonassaint, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh
  • Ana Radovic, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh
  • Alicia Colvin, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03
Study Completion Date2028-05

Study Record Updates

Study Start Date2025-03
Study Completion Date2028-05

Terms related to this study

Keywords Provided by Researchers

  • Sickle Cell Disease
  • Pain management
  • Cognitive Behavioral Therapy
  • Wellness

Additional Relevant MeSH Terms

  • Pain
  • Sickle Cell Disease